MetagenBio
"Innovating Healing, Transforming Lives"
To be a global leader in regenerative medicine by continuously advancing 3D MSC technology,
developing next-generation therapeutics, and shaping the future of personalized medicine.
20
23
October
Became a member of the Korea Artificial Intelligence Association
22
July
Filed a patent for a non-invasive dementia prediction platform and its diagnostic method
June
Registered patent for deep learning-based dementia prediction method
21
October
Became a member of the Korea Artificial Intelligence Association
June
Filed a patent for an AI-based dementia prediction system and self-diagnosis method using it
April
Certified as a venture company (R&D type)
February
Certified as a performance-sharing company
20
September
Relocated headquarters to Suwon City, Gyeonggi Province
July
Selected for the strategic startup project under the Small and Medium Business Technology Development Program
March
Registered as a responsible seller of cosmetics
February
Became a member of the Korea Artificial Intelligence Association
19
December
- Filed a patent for a deep learning-based dementia prediction method
- Registered as a research institute company
November
- Established Gyeonggi Branch in Pangyo 2nd Techno Valley
- Relocated headquarters to Jeonju City
April
- Certified as an excellent company in technology evaluation
- Certified as a venture company
March
- Moved headquarters to Pangyo 2nd Techno Valley
- Recognized as a corporate-affiliated research institute
18
October
Filed a patent for a cell tracking device
17
December
Selected for the corporate-affiliated research institute installation project under the Industry-Academia-Research Cooperation Technology Development Program
April
Certified as a venture company
16
November
Selected for the first step project of the Industry-Academia-Research Cooperation Technology Development Program
September
Transferred patent for portable small animal cell incubator and its manufacturing method
15
April
Certified as a venture company
March
Established MetagenBio Inc.